Serum MicroRNAs 223 and 146a in Allergic Rhinitis Patients as Biomarkers for Efficacy of Sublingual Immunotherapy
Condition(s):Effects of ImmunotherapyLast Updated:December 20, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Effects of ImmunotherapyLast Updated:December 20, 2022Completed
Condition(s):Food AllergyLast Updated:February 22, 2023Enrolling by invitation
Condition(s):Immunotherapy; Lung CancerLast Updated:February 27, 2020Recruiting
Condition(s):Efficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) HNSCCLast Updated:February 17, 2023Active, not recruiting
Condition(s):EphA2 Positive Malignant Glioma; CAR-T Cell ImmunotherapyLast Updated:July 16, 2020Withdrawn
Condition(s):Efficacy, SelfLast Updated:March 28, 2023Completed
Condition(s):Unexplained Recurrent Miscarriage and Recurrent Implantation FailureLast Updated:April 11, 2018Completed
Condition(s):Multi-omics Technique; Nasopharyngeal Carcinoma; Recurrent and Metastatic Nasopharyngeal Carcinoma; Efficacy of Chemoradiotherapy and ImmunotherapyLast Updated:March 15, 2024Not yet recruiting
Condition(s):Hepatocellular Carcinoma; ImmunotherapyLast Updated:February 28, 2024Not yet recruiting
Condition(s):Urinary Bladder NeoplasmLast Updated:December 1, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.